The effect of doxycycline on shedding of the glycocalyx due to reactive oxygen species

Microvascular Research

Volumn 90, Issue , 2013, Pages 80-85

  Lipowsky, Herbert H ^a   Lescanic, Anne ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; HYPOXANTHINE; MICROSPHERE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE;

ANIMAL TISSUE; ARTICLE; CELL SURFACE; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; GLYCOCALYX; MALE; MESENTERY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; VENULE;

RATTUS;

ANIMALS; BLOOD FLOW VELOCITY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXYCYCLINE; ENDOTHELIAL CELLS; ENZYME ACTIVATION; FREE RADICAL SCAVENGERS; GLYCOCALYX; HYPOXANTHINE; MALE; MATRIX METALLOPROTEINASE INHIBITORS; MATRIX METALLOPROTEINASES; MESENTERY; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; OXIDATIVE STRESS; RATS; RATS, WISTAR; SPLANCHNIC CIRCULATION; SUPEROXIDE DISMUTASE; SUPEROXIDES; TIME FACTORS; VENULES; XANTHINE OXIDASE;

EID: 84888429454     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2013.07.004     Document Type: Article

References (66)

1. Adamson R.H. Permeability of frog mesenteric capillaries after partial pronase digestion of the endothelial glycocalyx. J. Physiol. 1990, 428:1-13.
2. Akamatsu H., Asada M., Komura J., Asada Y., Niwa Y. Effect of doxycycline on the generation of reactive oxygen species: a possible mechanism of action of acne therapy with doxycycline. Acta Derm. Venereol. 1992, 72:178-179.
3. Arisaka T., Mitsumata M., Kawasumi M., Tohjima T., Hirose S., Yoshida Y. Effects of shear stress on glycosaminoglycan synthesis in vascular endothelial cells. Ann. N. Y. Acad. Sci. 1995, 748:543-554.
4. Becker B.F., Chappell D., Jacob M. Endothelial glycocalyx and coronary vascular permeability: the fringe benefit. Basic Res. Cardiol. 2010, 105:687-701.
5. Bruegger D., Jacob M., Rehm M., Loetsch M., Welsch U., Conzen P., Becker B.F. Atrial natriuretic peptide induces shedding of endothelial glycocalyx in coronary vascular bed of guinea pig hearts. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:H1993-H1999.
6. Cena J.J., Lalu M.M., Cho W.J., Chow A.K., Bagdan M.L., Daniel E.E., Castro M.M., Schulz R. Inhibition of matrix metalloproteinase activity in vivo protects against vascular hyporeactivity in endotoxemia. Am. J. Physiol. Heart Circ. Physiol. 2010, 298:H45-H51.
7. Chappell D., Hofmann-Kiefer K., Jacob M., Rehm M., Briegel J., Welsch U., Conzen P., Becker B.F. TNF-alpha induced shedding of the endothelial glycocalyx is prevented by hydrocortisone and antithrombin. Basic Res. Cardiol. 2009, 104:78-89.
8. Chappell D., Jacob M., Paul O., Rehm M., Welsch U., Stoeckelhuber M., Conzen P., Becker B.F. The glycocalyx of the human umbilical vein endothelial cell: an impressive structure ex vivo but not in culture. Circ. Res. 2009, 104:1313-1317.
9. Colburn P., Kobayashi E., Buonassisi V. Depleted level of heparan sulfate proteoglycan in the extracellular matrix of endothelial cell cultures exposed to endotoxin. J. Cell. Physiol. 1994, 159:121-130.
10. Constantinescu A.A., Vink H., Spaan J.A. Elevated capillary tube hematocrit reflects degradation of endothelial cell glycocalyx by oxidized LDL. Am. J. Physiol. Heart Circ. Physiol. 2001, 280:H1051-H1057.
11. Del Maestro R.F., Bjork J., Arfors K.E. Increase in microvascular permeability induced by enzymatically generated free radicals. I. In vivo study. Microvasc. Res. 1981, 22:239-254.
12. Del Maestro R.F., Bjork J., Arfors K.E. Increase in microvascular permeability induced by enzymatically generated free radicals. II. Role of superoxide anion radical, hydrogen peroxide, and hydroxyl radical. Microvasc. Res. 1981, 22:255-270.
13. Del Maestro R.F., Planker M., Arfors K.E. Evidence for the participation of superoxide anion radical in altering the adhesive interaction between granulocytes and endothelium, in vivo. Int. J. Microcirc. Clin. Exp. 1982, 1:105-120.
14. Desjardins C., Duling B.R. Heparinase treatment suggests a role for the endothelial cell glycocalyx in regulation of capillary hematocrit. Am. J. Physiol. 1990, 258:H647-H654.
15. Endo K., Takino T., Miyamori H., Kinsen H., Yoshizaki T., Furukawa M., Sato H. Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration. J. Biol. Chem. 2003, 278:40764-40770.
16. Fitzgerald M.L., Wang Z., Park P.W., Murphy G., Bernfield M. Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase. J. Cell Biol. 2000, 148:811-824.
17. Florian J.A., Kosky J.R., Ainslie K., Pang Z., Dull R.O., Tarbell J.M. Heparan sulfate proteoglycan is a mechanosensor on endothelial cells. Circ. Res. 2003, 93:e136-e142.
18. Fux L., Ilan N., Sanderson R.D., Vlodavsky I. Heparanase: busy at the cell surface. Trends Biochem. Sci. 2009, 34:511-519.
19. Gaboury J., Woodman R.C., Granger D.N., Reinhardt P., Kubes P. Nitric oxide prevents leukocyte adherence: role of superoxide. Am. J. Physiol. 1993, 265:H862-H867.
20. Gao L., Lipowsky H.H. Composition of the endothelial glycocalyx and its relation to its thickness and diffusion of small solutes. Microvasc. Res. 2010, 80:394-401.
21. Golub L.M., Lee H.M., Ryan M.E., Giannobile W.V., Payne J., Sorsa T. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv. Dent. Res. 1998, 12:12-26.
22. Gotte M. Syndecans in inflammation. FASEB J. 2003, 17:575-591.
23. Gouverneur M., Spaan J.A., Pannekoek H., Fontijn R.D., Vink H. Fluid shear stress stimulates incorporation of hyaluronan into endothelial cell glycocalyx. Am. J. Physiol. Heart Circ. Physiol. 2006, 290:H458-H462.
24. Grimm J., Keller R., de Groot P.G. Laminar flow induces cell polarity and leads to rearrangement of proteoglycan metabolism in endothelial cells. Thromb. Haemost. 1988, 60:437-441.
25. Gronski T.J., Martin R.L., Kobayashi D.K., Walsh B.C., Holman M.C., Huber M., Van Wart H.E., Shapiro S.D. Hydrolysis of a broad spectrum of extracellular matrix proteins by human macrophage elastase. J. Biol. Chem. 1997, 272:12189-12194.
26. Haldenby K.A., Chappell D.C., Winlove C.P., Parker K.H., Firth J.A. Focal and regional variations in the composition of the glycocalyx of large vessel endothelium. J. Vasc. Res. 1994, 31:2-9.
27. Henry C.B., Duling B.R. Permeation of the luminal capillary glycocalyx is determined by hyaluronan. Am. J. Physiol. 1999, 277:H508-H514.
28. Henry C.B., Duling B.R. TNF-alpha increases entry of macromolecules into luminal endothelial cell glycocalyx. Am. J. Physiol. Heart Circ. Physiol. 2000, 279:H2815-H2823.
29. Hofmann-Kiefer K.F., Kemming G.I., Chappell D., Flondor M., Kisch-Wedel H., Hauser A., Pallivathukal S., Conzen P., Rehm M. Serum heparan sulfate levels are elevated in endotoxemia. Eur. J. Med. Res. 2009, 14:526-531.
30. Huxley V.H., Williams D.A. Role of a glycocalyx on coronary arteriole permeability to proteins: evidence from enzyme treatments. Am. J. Physiol. Heart Circ. Physiol. 2000, 278:H1177-H1185.
31. Ihrcke N.S., Platt J.L. Shedding of heparan sulfate proteoglycan by stimulated endothelial cells: evidence for proteolysis of cell-surface molecules. J. Cell. Physiol. 1996, 168:625-637.
32. Ihrcke N.S., Wrenshall L.E., Lindman B.J., Platt J.L. Role of heparan sulfate in immune system-blood vessel interactions. Immunol. Today 1993, 14:500-505.
33. Lipowsky H.H., Haynes C.A. Synthesis of an artificial glycocalyx for studies of leukocyte adhesion. Proceedings of the 2005 Summer Bioengineering Conference, Vail, CO, June 22-26 2005, (abstract 247851).
34. Lipowsky H.H., Zweifach B.W. Application of the "two-slit" photometric technique to the measurement of microvascular volumetric flow rates. Microvasc. Res. 1978, 15:93-101.
35. Lipowsky H.H., Gao L., Lescanic A. Shedding of the endothelial glycocalyx in arterioles, capillaries and venules and its effect on capillary hemodynamics during inflammation. Am. J. Physiol. Heart Circ. Physiol. 2011, 301:H2235-H2245.
36. Lipowsky H.H., Sah R., Lescanic A. Relative roles of doxycycline and cation chelation in endothelial glycan shedding and adhesion of leukocytes. Am. J. Physiol. Heart Circ. Physiol. 2011, 300:H415-H422.
37. Mulivor A.W., Lipowsky H.H. Role of glycocalyx in leukocyte-endothelial cell adhesion. Am. J. Physiol. Heart Circ. Physiol. 2002, 283:H1282-H1291.
38. Mulivor A.W., Lipowsky H.H. Inflammation- and ischemia-induced shedding of venular glycocalyx. Am. J. Physiol. Heart Circ. Physiol. 2004, 286:H1672-H1680.
39. Mulivor A.W., Lipowsky H.H. Inhibition of glycan shedding and leukocyte-endothelial adhesion in postcapillary venules by suppression of matrix metalloprotease activity with doxycycline. Microcirculation 2009, 16:657-666.
40. Park P.W., Reizes O., Bernfield M. Cell surface heparan sulfate proteoglycans: selective regulators of ligand-receptor encounters. J. Biol. Chem. 2000, 275:29923-29926.
41. Parks D.A., Shah A.K., Granger D.N. Oxygen radicals: effects on intestinal vascular permeability. Am. J. Physiol. 1984, 247:G167-G170.
42. Platt J.L., Vercellotti G.M., Lindman B.J., Oegema T.R., Bach F.H., Dalmasso A.P. Release of heparan sulfate from endothelial cells. Implications for pathogenesis of hyperacute rejection. J Exp Med 1990, 171:1363-1368.
43. Platt J.L., Dalmasso A.P., Lindman B.J., Ihrcke N.S., Bach F.H. The role of C5a and antibody in the release of heparan sulfate from endothelial cells. Eur. J. Immunol. 1991, 21:2887-2890.
44. Pries A.R., Secomb T.W., Jacobs H., Sperandio M., Osterloh K., Gaehtgens P. Microvascular blood flow resistance: role of endothelial surface layer. Am. J. Physiol. 1997, 273:H2272-H2279.
45. Pries A.R., Secomb T.W., Gaehtgens P. The endothelial surface layer. Pflugers Arch. 2000, 440:653-666.
46. Purushothaman A., Uyama T., Kobayashi F., Yamada S., Sugahara K., Rapraeger A.C., Sanderson R.D. Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis. Blood 2010, 115:2449-2457.
47. Raats C.J., Bakker M.A., van den Born J., Berden J.H. Hydroxyl radicals depolymerize glomerular heparan sulfate in vitro and in experimental nephrotic syndrome. J. Biol. Chem. 1997, 272:26734-26741.
48. Ramamurthy N.S., Vernillo A.T., Greenwald R.A., Lee H.M., Sorsa T., Golub L.M., Rifkin B.R. Reactive oxygen species activate and tetracyclines inhibit rat osteoblast collagenase. J. Bone Miner. Res. 1993, 8:1247-1253.
49. Rehm M., Bruegger D., Christ F., Conzen P., Thiel M., Jacob M., Chappell D., Stoeckelhuber M., Welsch U., Reichart B., Peter K., Becker B.F. Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation 2007, 116:1896-1906.
50. Reitsma S., Slaaf D.W., Vink H., van Zandvoort M.A., oude Egbrink M.G. The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch. 2007, 454:345-359.
51. Spinale F.G. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol. Rev. 2007, 87:1285-1342.
52. Subramanian S.V., Fitzgerald M.L., Bernfield M. Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation. J. Biol. Chem. 1997, 272:14713-14720.
53. Svennevig K., Hoel T., Thiara A., Kolset S., Castelheim A., Mollnes T., Brosstad F., Fosse E., Svennevig J. Syndecan-1 plasma levels during coronary artery bypass surgery with and without cardiopulmonary bypass. Perfusion 2008, 23:165-171.
54. Taraboletti G., D'Ascenzo S., Borsotti P., Giavazzi R., Pavan A., Dolo V. Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am. J. Pathol. 2002, 160:673-680.
55. Teoh M.L., Fitzgerald M.P., Oberley L.W., Domann F.E. Overexpression of extracellular superoxide dismutase attenuates heparanase expression and inhibits breast carcinoma cell growth and invasion. Cancer Res. 2009, 69:6355-6363.
56. van Haaren P.M., VanBavel E., Vink H., Spaan J.A. Localization of the permeability barrier to solutes in isolated arteries by confocal microscopy. Am. J. Physiol. Heart Circ. Physiol. 2003, 285:H2848-H2856.
57. Vink H., Duling B.R. Identification of distinct luminal domains for macromolecules, erythrocytes, and leukocytes within mammalian capillaries. Circ. Res. 1996, 79:581-589.
58. Vink H., Duling B.R. Capillary endothelial surface layer selectively reduces plasma solute distribution volume. Am. J. Physiol. Heart Circ. Physiol. 2000, 278:H285-H289.
59. Vlodavsky I., Ilan N., Naggi A., Casu B. Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate. Curr. Pharm. Des. 2007, 13:2057-2073.
60. Weinbaum S., Tarbell J.M., Damiano E.R. The structure and function of the endothelial glycocalyx layer. Annu. Rev. Biomed. Eng. 2007, 9:121-167.
61. Williams D.A. Change in shear stress (Deltatau)/hydraulic conductivity (Lp) relationship after pronase treatment of individual capillaries in situ. Microvasc. Res. 2007, 73:48-57.
62. Yaras N., Sariahmetoglu M., Bilginoglu A., Aydemir-Koksoy A., Onay-Besikci A., Turan B., Schulz R. Protective action of doxycycline against diabetic cardiomyopathy in rats. Br. J. Pharmacol. 2008, 155:1174-1184.
63. Yu W.H., Woessner J.F. Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7). J. Biol. Chem. 2000, 275:4183-4191.
64. Zcharia E., Jia J., Zhang X., Baraz L., Lindahl U., Peretz T., Vlodavsky I., Li J.P. Newly generated heparanase knock-out mice unravel co-regulation of heparanase and matrix metalloproteinases. PLoS One 2009, 4:e5181.
65. Zhu L., He P. fMLP-stimulated release of reactive oxygen species from adherent leukocytes increases microvessel permeability. Am. J. Physiol. Heart Circ. Physiol. 2006, 290:H365-H372.
66. Zuurbier C.J., Demirci C., Koeman A., Vink H., Ince C. Short-term hyperglycemia increases endothelial glycocalyx permeability and acutely decreases lineal density of capillaries with flowing red blood cells. J. Appl. Physiol. 2005, 99:1471-1476.